In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sysmex Corp.

www.sysmex.com

Latest From Sysmex Corp.

New Top Exec Reshuffle To Steer OGT Down Dx Path

Oxford Gene Technology has appointed its former head of R&D, John Anson, as CEO and brought in a new head of regulatory affairs, Paul Kenny, as the company shifts resources to the molecular diagnostics market.

In Vitro Diagnostics Appointments

genedrive Signs Sysmex To Distribute Decentralized-Setting HCV Test

Molecular diagnostics company genedrive has signed a distribution agreement with Sysmex Corporation to distribute its CE-marked HepC (HCV) ID kit and Genedrive platform in the Europe, Middle East and Africa. The Japanese group is the first commercial partner for genedrive's hepatitis C test for decentralized resource-limited settings.

Commercial Medical Device

Using Surrogate Samples For IVD Trials: MDIC Issues A Framework

The group that helped developed a framework to incorporate patient preference data into regulatory device submissions has released a new document to help in vitro diagnostics sponsors tackle the problem of limited sampling by using surrogate samples. The plan has been reviewed by top FDA officials.

In Vitro Diagnostics Regulation

Sysmex Buys OGT To Add Cytogenics Capability

Oxford Gene Technology announced May 31 that it will become a wholly owned subsidiary of Sysmex, the Japanese in vitro diagnostics company that will gain entry into the cytogenetics market with OGT's fluorescence in situ hybridization and array comparative genomic hybridization products.

Deals Companies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Hematology, Coagulation
    • Urine-based Testing
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Sysmex Corp.
  • Senior Management
  • Hisashi Ietsugu, Chmn. & CEO
  • Contact Info
  • Sysmex Corp.
    Phone: (81) 78-265-0500
    1-5-1 Wakinohama-kgandori
    Chuo-ku
    Kobe, Hyogo, 651-0073
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register